Hvivo
Quick facts
Phase 2 pipeline
- G-004 · Diabetes
G-004 is a small molecule that targets the SGLT2 receptor.
Phase 1 pipeline
- Experimental: Protesomal Vaccine 1 x 30 µg
- Experimental: Protesomal Vaccine 2 x 15 µg
- Experimental: Protesomal Vaccine 2 x 30 µg
- High Titre Influenza virus
- Low titre
- Medium - High Influenza virus
- Medium Low Titre Influenza virus
- SARS-CoV-2 omicron virus dose arm 1
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: